Johannesburg - Aspen Pharmacare Holdings [JSE:APN] said on
Monday it has finalised the acquisition of medicines from GlaxoSmithKline for
£163.8m.
The deal, announced in August, was initially pegged at £172m.
Johannesburg - Aspen Pharmacare Holdings [JSE:APN] said on
Monday it has finalised the acquisition of medicines from GlaxoSmithKline for
£163.8m.
The deal, announced in August, was initially pegged at £172m.
Find public sector tender opportunities in South Africa here.